AskBio
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · North Carolina, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
20 Tw Alexander Dr Ste 110, Durham, Nort...Phone Number
(919) 561-6210Website
www.askbio.comRevenue
$19.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About AskBio
AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of transformative gene therapeutics, pioneering research and development, groundbreaking synthetic biology, and scalable cGMP manufacturing. Its robust pipeline includes gene therapy candidates at various clinical stages for neuromuscular, central nervous system, metabolic, and cardiovascular diseases. AskBio also has a portfolio of over 775 molecular and genetic medicine patents and an expansive library of capsids and promoters. Global headquarters are in RTP, NC, and European headquarters in Edinburgh. AskBios AAV research centers are in Philadelphia, PA; Columbus, OH; and Paris. Modern clinical, commercial, and synthetic DNA manufacturing facilities are in San Sebastian, Spain. AskBio is a wholly owned, independently operated subsidiary of Bayer.Explore more
AskBio Org Chart
BC
Vice President, Gmp Quality
YH
Vice President, Clinical Development
BB
Vice President, Gmp Quality
AH
Vice President, Manufacturing Science & Techn...
JS
Vice President, Bd & Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AskBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AskBio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AskBio has new funding data
Earning: See what the market has to say on AskBio recently announced quarterly report
Check out if AskBio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when AskBio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if AskBio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at AskBio
AskBio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to AskBio
Compare insights from companies similar to AskBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AskBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AskBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AskBio.
AskBio financials insights
Gather financial insights about AskBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Grant
$1.6M
2020
Grant
$2.6M
AskBio Tech Stack
A closer look at the technologies used by AskBio
Most Recent Scoops
Hiring Plans
AskBio is hiring in Marketing for the first time in 12 months.
Hiring Plans
Open Position
Open Position
Project
, according to a high-level source in medical
Project
Audit, Compliance, Workforce Management, Internal Audit & Control, Artificial Intelligence, Finance
AskBio News & Media
AskBio Announces 6 Presentations at American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Durham, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver 6 presentations at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting, which takes place May 11–15, 2026, in Boston, Massachusetts, USA. The company’s oral and poster presentations will provide updates on important research activities in gene therapy, as well as subsidiary Viralgen’s advancements inAskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Berlin, Germany, and Durham, N.C., USA, April 20, 2026 (GLOBE NEWSWIRE) -- Not intended for UK MediaAskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the randomization of the last participant was completed earlier this year for GenePHIT, its Phase 2 clinical trial of AB-1002, an investigational gene therapy being developed as a potential treatment for heart failure with reduced ejection fraction (HFrEF).Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease
SHANGHAI, Jan. 14, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND)...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AskBio
Sign Up For FreeTo access detailed company insights
AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of transformative gene therapeutics, pioneering research and development, groundbreaking synthetic biology, and scalable cGMP manufacturing. Its robust pipeline includes gene therapy candidates at var... Read More
